Clinical trial
Claudication: Exercise Versus Endoluminal Revascularization (CLEVER)
NCT00132743 · Joselyn Cerezo, MD, Other · Unknown status
Key facts
| NCT number | NCT00132743 |
|---|---|
| Title | Claudication: Exercise Versus Endoluminal Revascularization (CLEVER) |
| Official title | Claudication: Exercise Versus Endoluminal Revascularization (CLEVER) |
| Acronym | CLEVER |
| Lead sponsor | Joselyn Cerezo, MD, Other |
| Collaborators | National Heart, Lung, and Blood Institute (NHLBI) NIH |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Cardiovascular Diseases, Peripheral Vascular Diseases, Atherosclerosis |
| Intervention type | Behavioral, Device, Drug |
| Interventions | Stent, Supervised Exercise Therapy, Cilostazol |
| Enrollment | 119 |
| Start date | Feb 1, 2007 |
| Primary completion | Jul 1, 2013 |
| Completion | Jul 1, 2013 |
| First posted | Aug 22, 2005 |
| Last update posted | Apr 25, 2013 |
| Countries | Canada, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: